Targeted treatment planning is key to the success of external beam radiotherapy. Conventional treatment planning workflows are based on the registration
of an MRI dataset with a primary CT dataset. This approach has several drawbacks such as not only being laborious but also having the potential
for misalignment errors in the registration process.
This article summarizes Philips MRCAT (Magnetic Resonance for Calculating ATtenuation) solution for an MR-only based dose planning approach for external
beam radiation therapy and the first clinical application of the commercially available system for prostate cancer [1].
beam radiation therapy and the first clinical application of the commercially available system for prostate cancer [1].